Gennova CEO Singh On India’s mRNA Vaccine, Using Tech Against Cancer, Potential Equity Partnering

Gennova Biopharma’s founder CEO Sanjay Singh talks to Scrip on developing the first Indian and the world’s third mRNA vaccine against COVID-19, following Moderna and Pfizer. After a couple of years in the US at The National Institutes of Health, he returned to set up the company, which is looking at using the technology against cancer and infectious diseases like dengue and is now being sought by funds/companies for an equity stake https://scrip.pharmaintelligence.informa.com/SC146770/CEO-Of-Indias-mRNA-Pioneer-Gennova-On-Cancer-Vaccines-VC-Interest